Skip to main content

Valantine Hannah's Form 4 filing

BridgeBio Pharma, Inc. (BBIO) · filed Jun 24, 2026

Accession no.
0001470831-26-000635
Filed
Jun 24, 2026
Trade date
Jun 22-23, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $341.5K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Valantine HannahCIK 0001855608Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 22, 2026Common StockAGrant or awardAcquired+3,990$0.00F2$011,455Direct
Jun 22, 2026Common StockMOption exerciseAcquired+2,808$41.73+$117,177.8414,263Direct
Jun 22, 2026Common StockSSaleDisposed−2,808$68.00−$190,94411,455Direct
Jun 23, 2026Common StockSSaleDisposed−2,196$68.57−$150,579.729,259Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 22, 2026Common StockAGrant or awardAcquired+5,277$0.00$05,277Direct
Jun 22, 2026Common StockMOption exerciseDisposed−2,808$0.00$05,617Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)